Distinct features and functions of systemic and mucosal humoral immunity among SARS-CoV-2 convalescent individuals
SE Butler, AR Crowley, H Natarajan, S Xu… - Frontiers in …, 2021 - frontiersin.org
Understanding humoral immune responses to SARS-CoV-2 infection will play a critical role
in the development of vaccines and antibody-based interventions. We report systemic and …
in the development of vaccines and antibody-based interventions. We report systemic and …
A randomized phase 4 study of immunogenicity and safety after monovalent oral type 2 Sabin poliovirus vaccine challenge in children vaccinated with inactivated …
AS Bandyopadhyay, C Gast, EB Brickley… - The Journal of …, 2021 - academic.oup.com
Background Understanding immunogenicity and safety of monovalent type 2 oral poliovirus
vaccine (mOPV2) in inactivated poliovirus vaccine (IPV)–immunized children is of major …
vaccine (mOPV2) in inactivated poliovirus vaccine (IPV)–immunized children is of major …
Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine
T Zhao, J Li, H Shi, H Ye, R Ma, Y Fu, X Liu… - Human Vaccines & …, 2021 - Taylor & Francis
The switch from using only trivalent oral polio vaccine (tOPV) to sequential schedules
combining inactivated poliovirus vaccine (IPV) and bivalent oral polio vaccine (bOPV) for …
combining inactivated poliovirus vaccine (IPV) and bivalent oral polio vaccine (bOPV) for …
Immunogenicity of sequential poliovirus vaccination schedules with different strains of poliomyelitis vaccines in Chongqing, China: a cross-sectional survey
J Xu, Q Wang, S Kuang, R Rong, Y Zhang… - Human Vaccines & …, 2021 - Taylor & Francis
ABSTRACT A new vaccination schedule with one dose of inactivated polio vaccine (IPV)
followed by three doses of bivalent oral attenuated live polio vaccine (bOPV) was introduced …
followed by three doses of bivalent oral attenuated live polio vaccine (bOPV) was introduced …
Development of a Quantitative One-Step RT-PCR Method for the Detection of Sabin 2 Virus Contamination in a Novel Oral Poliovirus Vaccine Type 2
H Manukyan, E Tritama, R Wahid, A Ansari, J Konz… - Vaccines, 2021 - mdpi.com
To control circulating vaccine-derived type 2 poliovirus outbreaks, a more genetically stable
novel Oral Poliovirus Vaccine type 2 (nOPV2) was developed by targeted modifications of …
novel Oral Poliovirus Vaccine type 2 (nOPV2) was developed by targeted modifications of …
Effect of maternal HIV and malaria on the transplacental transfer of antibodies against prevalent pathogens and vaccines in Mozambican women
S Alonso Galindo - 2021 - diposit.ub.edu
[eng] Infectious diseases are one of the main causes of mortality in newborns born in
Mozambique. Transplacental transfer of antibodies is essential for conferring protection …
Mozambique. Transplacental transfer of antibodies is essential for conferring protection …
Poliovirus 1 Seroprevalence in Nova Scotia, Canada
MS ElSherif - 2021 - dalspace.library.dal.ca
Thanks to the efforts of the Global Polio Eradication Initiative, the world has never been
closer to eradicating polio as it is today. Without complete eradication from the remaining …
closer to eradicating polio as it is today. Without complete eradication from the remaining …
[PDF][PDF] City, Panama 4. Sistema Nacional de Investigación, Senacyt, Panama 5. Cevaxin, Panama City, Panama 6. VaxTrials, Panama City, Panama 7. Fighting …
C Gast, AS Bandyopadhyay, X Sáez-Llorens… - 2021 - scholar.archive.org
Accepted Manuscript Page 1 Accepted Manuscript © The Author(s) 2021. Published by
Oxford University Press for the Infectious Diseases Society of America. This is an Open …
Oxford University Press for the Infectious Diseases Society of America. This is an Open …